Literature DB >> 1977371

Prednisone effects on neurochemistry and behavior. Preliminary findings.

O M Wolkowitz1, D Rubinow, A R Doran, A Breier, W H Berrettini, M A Kling, D Pickar.   

Abstract

To evaluate the neurochemical, neuroendocrine, and behavioral effects of exogenous corticosteroids in humans, we administered prednisone (80 mg/d orally for 5 days) in a double-blind manner to 12 medically healthy volunteers. Behavioral measures were assessed before, during, and after prednisone administration in all 12 subjects, and cerebrospinal fluid biochemistry was assessed before and during prednisone administration in 9 of the subjects. Prednisone administration was associated with decreases in cerebrospinal fluid levels of corticotropin, norepinephrine, beta-endorphin, beta-lipotropin, and somatostatinlike immunoreactivity. No significant changes were noted in cerebrospinal fluid levels of alpha-melanocyte-stimulating hormone, corticotropin-releasing hormone, 3-methoxy-4-hydroxyphenylglycol, homovanillic acid, or 5-hydroxyindoleacetic acid. No consistent or significant group mean changes were observed in structured behavioral ratings, although 9 (75%) of the volunteers studied reported mild behavioral changes while receiving prednisone. Correlations between the neurochemical and behavioral changes are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977371     DOI: 10.1001/archpsyc.1990.01810220079010

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  25 in total

1.  Inhaled steroid-induced mania in an adolescent girl: a case report.

Authors:  Saira Khan; Jabeen Hayat; Shakeel Raza
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Successful treatment of steroid-induced panic disorder with fluvoxamine.

Authors:  Y Charbonneau; A V Ravindran
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

3.  Systemic and Local Corticosteroid Use Is Associated with Reduced Executive Cognition, and Mood and Anxiety Disorders.

Authors:  Mesut Savas; Christiaan H Vinkers; Judith G M Rosmalen; Catharina A Hartman; Vincent L Wester; Erica L T van den Akker; Anand M Iyer; Bruce S McEwen; Elisabeth F C van Rossum
Journal:  Neuroendocrinology       Date:  2019-06-21       Impact factor: 4.914

4.  Corticosteroid-induced psychiatric disorders: genetic studies are needed.

Authors:  Florence Thibaut
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-09       Impact factor: 5.270

Review 5.  Corticosteroids, immune suppression, and psychosis.

Authors:  Dana C Perantie; E Sherwood Brown
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

6.  Factors affecting sleep quality of patients in intensive care unit.

Authors:  Shailesh Bihari; R Doug McEvoy; Elisha Matheson; Susan Kim; Richard J Woodman; Andrew D Bersten
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

7.  A comparison of clinician-rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders.

Authors:  Alan B Frol; Aracely Vasquez; Yonatan Getahun; Maria Pacheco; David A Khan; E Sherwood Brown
Journal:  Allergy Asthma Proc       Date:  2013 Mar-Apr       Impact factor: 2.587

Review 8.  Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

Authors:  B Dubrovsky
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

9.  Effects of adrenocortical steroids on long-term potentiation in the limbic system: basic mechanisms and behavioral consequences.

Authors:  B Dubrovsky; K Gijsbers; D Filipini; M K Birmingham
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

10.  Emotional lability secondary to the application of a very potent topical corticosteroid.

Authors:  Srinivasa Sastry Malladi
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.